PMID: 9425690May 1, 1997Paper

Increased drug reactions in HIV-1-positive patients: a possible explanation based on patterns of immune dysregulation seen in HIV-1 disease. The Military Medical Consortium for the Advancement of Retroviral Research (MMCARR)

Clinical and Experimental Dermatology
K J SmithK F Wagner

Abstract

Drug reactions are common in HIV-1 disease, with the incidence having been reported to increase with increasing stage and with CD4+ T-cell counts below 200/microliters. However, there have been numerous reports of patients in which rechallenge, dosing changes or continued therapy have resulted in no recurrence or else clearing of the eruption. We followed 974 HIV-1-positive patients for 46 months as a part of a military study of HIV-1 disease. Within this group there were a total of 283 drug eruptions, with cutaneous manifestations in 201 patients in which clinical characteristics were noted and 86 patients in which cutaneous biopsies were performed. Serological evidence of reactivation or acute Epstein-Barr virus (EBV) or cytomegalovirus (CMV) infections were also noted, as well as peripheral eosinophilia. The incidence of drug eruptions significantly increased with increasing Walter Reed stage and decreasing CD4 counts and CD4/CD8 ratio, as well as with increasing age and in patients with increased numbers of other dermatological diagnoses. In addition, white patients had significantly more drug eruptions than did black. Serological or culture evidence of acute or reactivated EBV or CMV was significantly increased in patients...Continue Reading

References

Jan 1, 1992·The Journal of Allergy and Clinical Immunology·D Israël-BietP Even
Nov 1, 1992·Archives of Dermatology·J D BosM L Kapsenberg
Oct 1, 1992·International Journal of Immunopharmacology·M J RiederW Y Almawi
Dec 1, 1992·Journal of Acquired Immune Deficiency Syndromes : JAIDS·P J BayardM A Jacobson
Jun 1, 1990·Canadian Journal of Physiology and Pharmacology·K W Renton, L C Knickle
Feb 1, 1992·The Pediatric Infectious Disease Journal·J W Bass
May 1, 1991·Archives of Dermatology·S A Coopman, R S Stern
May 1, 1990·The American Journal of Medicine·J Torgovnick, E Arsura
Feb 1, 1990·The Journal of Allergy and Clinical Immunology·D N WrightR F Lockey
Dec 1, 1988·The Journal of Clinical Investigation·N H Shear, S P Spielberg
Feb 26, 1988·JAMA : the Journal of the American Medical Association·M A FischlL La Voie
Feb 1, 1987·Annals of Internal Medicine·R M SmithJ P Flaherty
Nov 1, 1986·The Journal of Allergy and Clinical Immunology·I Finegold
Feb 1, 1987·Annals of Internal Medicine·S A Brody
Mar 1, 1987·The Journal of Allergy and Clinical Immunology·P A Greenberger, R Patterson
Mar 1, 1985·JAMA : the Journal of the American Medical Association·R B Gibbons, J A Lindauer
Nov 8, 1969·Lancet·S ShapiroH Jick
Feb 3, 1973·British Medical Journal·I Gregg
Jan 1, 1970·Scandinavian Journal of Infectious Diseases·E Klemola
Jun 1, 1982·The Journal of Allergy and Clinical Immunology·T J Sullivan
Jun 30, 1982·Biochemical and Biophysical Research Communications·G SinghN Stebbing
Mar 1, 1982·The Journal of Allergy and Clinical Immunology·T J SullivanH J Wedner
Aug 1, 1994·Immunological Reviews·S RomagnaniP Parronchi
Dec 1, 1994·Immunology Today·M Clerici, G M Shearer
Feb 1, 1995·Immunology Today·G Del PreteS Romagnani
Mar 1, 1993·Immunology Today·M Clerici, G M Shearer
Aug 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·S C FloresJ M McCord
May 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·P A Sandstrom, T M Buttke

❮ Previous
Next ❯

Citations

Apr 20, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·O LaunayUNKNOWN Viramune-Zyrtec Study Group
Mar 12, 2003·American Journal of Clinical Dermatology·Fiza Singh, Donald Rudikoff
Dec 19, 2012·Indian Journal of Dermatology·Punit P SaraogiRachita S Dhurat
Jul 7, 2011·Journal of Oral and Maxillofacial Pathology : JOMFP·S BalasundaramPradeep Ambrose
May 1, 2007·Translational Research : the Journal of Laboratory and Clinical Medicine·Manuela G NeumanLawrence Cohen
Mar 31, 2015·Current Infectious Disease Reports·Kirstin AltmanRyan P Westergaard
Mar 19, 2014·Journal of the American Academy of Dermatology·Chao YangArturo Saavedra
Feb 17, 2007·Dermatitis : Contact, Atopic, Occupational, Drug·Daniel D Miller, Erin M Warshaw
Apr 7, 2018·International Journal of STD & AIDS·Roberta BilenchiMichele Fimiani
Jul 24, 2013·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·J CourjonP-M Roger
May 31, 2019·Current Opinion in Allergy and Clinical Immunology·Jonny PeterRannakoe J Lehloenya
Jun 7, 2019·Current Opinion in Allergy and Clinical Immunology·Miguel Blanca, Paul Whitaker
Apr 17, 2014·Clinical Reviews in Allergy & Immunology·Tetsuo ShioharaRyo Takahashi
Jul 1, 2016·Current Opinion in Allergy and Clinical Immunology·Sze-Chin Tan, Grace Y L Chan
Apr 3, 2004·Journal of Cutaneous Pathology·J M MucheN Haas
Nov 21, 1998·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·B SchnyderW J Pichler

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.